×
Phreesia Operating Expenses 2019-2024 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phreesia operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Phreesia Operating Expenses 2019-2024 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phreesia operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$38.9B
Tempus AI (TEM)
$10.2B
Hims & Hers Health (HIMS)
$8.8B
Inspire Medical Systems (INSP)
$5.4B
IRhythm Technologies (IRTC)
$3.4B
Privia Health (PRVA)
$2.7B
Enovis (ENOV)
$2.5B
Azenta (AZTA)
$2.5B
Clover Health Investments (CLOV)
$2.2B
Schrodinger (SDGR)
$1.9B
Omnicell (OMCL)
$1.8B
10x Genomics (TXG)
$1.8B
Butterfly Network (BFLY)
$937M
Talkspace (TALK)
$608M
Standard BioTools (LAB)
$529M
Fulgent Genetics (FLGT)
$507M
TruBridge (TBRG)
$380M
Nyxoah SA (NYXH)
$369M
Health Catalyst (HCAT)
$334M
Pulmonx (LUNG)
$254M
SOPHiA GENETICS SA (SOPH)
$233M
American Well (AMWL)
$176M
EUDA Health Holdings (EUDA)
$104M
MDxHealth SA (MDXH)
$87M
P3 Health Partners (PIII)
$73M
CareCloud (CCLD)
$66M
HeartBeam (BEAT)
$65M
111 (YI)
$57M
Zepp Health (ZEPP)
$45M
Outset Medical (OM)
$43M